Coronavirus / COVID-19 Pandemic Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

Sam

Stock Puppy

To: Moonray who wrote (291)	3/29/2020 11:08:44 AM
From: Moonray	2 Recommendations of 22884

Two more stories adding more details about the Abbott Labs Coronavirus Testing, like: The test runs on the company's ID NOW platform, a 6.6-pound portable device the size of a small toaster. There are currently about 18,000 ID NOW instruments in the U.S. – the most widely available molecular point-of-care testing platform in the nation, Frels said. More at: 'A game changer': FDA authorizes Abbott Labs' portable, 5-minute coronavirus test the size of a toaster And at: Abbott Launches 5-Minute Virus Test for Use Almost Anywhere On a stock note: Abbott Labs (ABT) has a PER of about 18 at its current $76 price. This seems reasonable and is about $16 from its 52-Week High. I doubt there is much long-term profit for ABT in these tests. However, the Abbott announcement occurred right after the post-market session and I would expect the opening bid on Monday's pre-market to be much higher. o~~~ O

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next